IP Library Granted Patent US 9,116,866
Granted Patent B2
US 9,116,866 · App. 14/041,850 · Granted Aug 25, 2015

Methods and systems for detecting sequence variants

Inventor: Deniz Kural (Somerville, MA)
Assignee: Seven Bridges Genomics Inc.
G06F19/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,116,866
App. No.
14/041,850
Granted
Aug 25, 2015
Kind
B2
Abstract

The invention provides methods for identifying rare variants near a structural variation in a genetic sequence, for example, in a nucleic acid sample taken from a subject. The invention additionally includes methods for aligning reads (e.g., nucleic acid reads) to a reference sequence construct accounting for the structural variation, methods for building a reference sequence construct accounting for the structural variation or the structural variation and the rare variant, and systems that use the alignment methods to identify rare variants. The method is scalable, and can be used to align millions of reads to a construct thousands of bases long, or longer.

Claims (20)

1. A method for identifying a mutation in proximity to a structural variation in a sequence, the method comprising the steps of:

obtaining a plurality of nucleic acid sequence reads, wherein at least one nucleic acid read comprises a mutation;

comparing said reads to a reference sequence construct, wherein said reference sequence construct is stored in computer memory as a directed acyclic graph comprising at least two alternative sequences at a position in the reference sequence construct, one of which is a structural variation,

scoring sequence overlaps for each nucleic acid read against the reference sequence construct;

aligning each read to a location on the construct such that the score for each read is maximized; and

identifying the mutation as being aligned within 100 bp or fewer of the structural variation.

2. The method of claim 1 , further comprising assembling the nucleic acid reads to each other based upon the alignment of the nucleic acid reads with respect to the reference sequence construct.

3. The method of claim 1 , wherein the structural variation is at least 100 bp long.

4. The method of claim 1 , wherein the reference sequence construct further comprises at least two additional alternative sequences at a second position in the reference construct, and one of the additional alternative sequences comprises a sequence matching the mutation.

5. The method of claim 4 , wherein the first and second positions are separated by 100 bp or fewer.

6. The method of claim 1 , wherein the reference sequence construct further comprises at least two additional alternative sequences at a second position in the reference construct, and neither of the additional alternative sequences comprises a sequence matching the mutation.

7. The method of claim 6 , wherein the first and second positions are separated by 100 bp or fewer.

8. The method of claim 1 , wherein the structural variation is 1 kilobase to 3 megabases in length.

9. The method of claim 1 , wherein the mutation was not previously identified in a variant call format (VCF) file.

10. The method of claim 1 , wherein the mutation was previously identified in a variant call format (VCF) file.

11. The method of claim 1 , wherein the structural variation is selected from the group consisting of deletions, duplications, copy-number variations, insertions, inversions, and translocations.

12. The method of claim 1 , wherein the mutation is selected from the group consisting of a deletion, a duplication, an inversion, an insertion, and a single nucleotide polymorphism.

13. The method of claim 1 , wherein the mutation does not comprise a sequence matching the reference construct.

14. The method of claim 1 , wherein the reference sequence construct comprises a genome of an organism.

15. The method of claim 1 , wherein the reference sequence comprises a chromosome of an organism.

Assignments (12)
SECURITY INTEREST Recorded Aug 4, 2022
From: PIERIANDX, INC.; SEVEN BRIDGES GENOMICS INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 061084/0786 →
RELEASE OF SECURITY INTEREST Recorded Aug 2, 2022
From: IMPERIAL FINANCIAL SERVICES B.V.
To: SEVEN BRIDGES GENOMICS INC.
Reel/Frame 061055/0078 →
SECURITY INTEREST Recorded May 24, 2022
From: SEVEN BRIDGES GENOMICS INC.
To: IMPERIAL FINANCIAL SERVICES B.V.
Reel/Frame 060173/0803 →
RELEASE OF SECURITY INTEREST Recorded May 24, 2022
From: IMPERIAL FINANCIAL SERVICES B.V.
To: SEVEN BRIDGES GENOMICS INC.
Reel/Frame 060173/0792 →
SECURITY INTEREST Recorded Mar 30, 2022
From: SEVEN BRIDGES GENOMICS INC.
To: IMPERIAL FINANCIAL SERVICES B.V.
Reel/Frame 059554/0165 →
TERMINATION AND RELEASE OF NOTICE OF ATTORNEY'S LIEN Recorded Sep 13, 2018
From: BROWN RUDNICK LLP
To: SEVEN BRIDGES GENOMICS INC.
Reel/Frame 046943/0683 →
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2018
From: MJOLK HOLDING BV
To: SEVEN BRIDGES GENOMICS INC.
Reel/Frame 045928/0013 →
SECURITY INTEREST Recorded Oct 17, 2017
From: SEVEN BRIDGES GENOMICS INC.
To: MJOLK HOLDING BV
Reel/Frame 044305/0871 →
NOTICE OF ATTORNEY'S LIEN Recorded Oct 11, 2017
From: SEVEN BRIDGES GENOMICS INC.
To: BROWN RUDNICK
Reel/Frame 044174/0113 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Oct 10, 2017
From: VENTURE LENDING & LEASING VII, INC.
To: SEVEN BRIDGES GENOMICS INC.; SEVEN BRIDGES GENOMICS UK LTD.; SEVEN BRIDGES GENOMICS D.O.O.
Reel/Frame 044174/0050 →
SECURITY INTEREST Recorded Mar 23, 2015
From: SEVEN BRIDGES GENOMICS INC.; SEVEN BRIDGES GENOMICS UK LIMITED
To: VENTURE LENDING & LEASING VII, INC.
Reel/Frame 035233/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2013
From: KURAL, DENIZ
To: SEVEN BRIDGES GENOMICS INC.
Reel/Frame 031685/0040 →
Continuity (3)
Provisional Application 61868249 · Aug 21, 2013
Provisional Application 61884380 · Sep 30, 2013
Related Publication 20150056613A1 · Feb 26, 2015